• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Topics » Science

Science
Science RSS Feed RSS

Lung cancer illustration

Lipid metabolism controls lung cancer metastasis, not just diseases like atherosclerosis

Sep. 30, 2020
By W. Todd Penberthy
Researchers working at the Jackson Laboratory Cancer Center reported in the September 21, 2020, issue of Nature Immunology that breast cancer cells induced neutrophils to accumulate lipids, which were transported to metastatic tumor cells through a macropinocytosis pathway, thus fueling the metastatic potential of tumor cells with lipids.
Read More

BioWorld MedTech’s Oncology Extra for Sept. 29, 2020

Sep. 29, 2020
By Mark McCarty and Anette Breindl
Keeping you up to date on recent developments in oncology, including: New nanoparticle could overcome aggregation-caused quenching for cancer treatment; Epigenetic resistance to PARP inhibitors; Statins help pancreatic tumors go from bad to worse; Sit up straight: PBT coming to a chair near you.
Read More
Ames test
Bench Press

Carcinogens need not be mutagens

Sep. 29, 2020
By Anette Breindl
BioWorld looks at translational medicine, including: Myelin regulatory factor helps out pancreatic cancer cells.
Read More
Brain-DNA illustration

Cerebral palsy risk has genetic component

Sep. 29, 2020
By John Fox
A U.S.-led international whole-exome sequencing study has discovered that mutations in genes encoding for the growth of the neurites necessary for neural connectivity increase the risk for cerebral palsy, the authors reported in the September 28, 2020, edition of Nature Genetics.
Read More

BioWorld MedTech’s Cardiology Extra for Sept. 28, 2020

Sep. 28, 2020
By Liz Hollis
Keeping you up to date on recent developments in cardiology, including: Using biomarkers to detect minor strokes; ACC, Novartis team up on heart failure; Scientists ID new abdominal aortic aneurysm genes.
Read More

BioWorld MedTech’s Neurology Extra for Sept. 25, 2020

Sep. 25, 2020
By Andrea Applegate and Anette Breindl
Keeping you up to date on recent developments in neurology, including: Putting virtual rehab for stroke patients to the test; Deep learning tool advances study of neural degeneration; Popular opinion correct on fear, anxiety.
Read More
Glucose testing

Reduced diabetes risk is side effect of HIV, hep B drug class

Sep. 25, 2020
By Anette Breindl
Researchers at the University of Virginia have used a retrospective database analysis to show that the use of nucleoside reverse transcriptase inhibitors for the treatment of HIV or hepatitis B reduced the risk of developing type 2 diabetes by 33%.
Read More
Cancer cell, dropper, test tubes

Using tumor organoids, researchers identify recurrent, druggable neuroblastoma targets

Sep. 25, 2020
By Nuala Moran
Using 3D tumor organoids, researchers have added to existing evidence that inhibition of kinesin spindle protein (KSP) may represent a broadly relevant target for the treatment of the aggressive childhood tumor neuroblastoma.
Read More

BioWorld MedTech’s Diagnostics Extra for Sept. 24, 2020

Sep. 24, 2020
By Meg Bryant
Keeping you up to date on recent developments in diagnostics, including: Distinguishing metastatic SLNs in breast cancer; MRS method reveals insights into Alzheimer’s disease; SARS-CoV-2 multiplex assay allows 3x as many patients per run.
Read More
Brain circuits
Bench Press

Popular opinion correct on fear, anxiety

Sep. 24, 2020
By Anette Breindl
BioWorld looks at translational medicine, including: Buyer beware for SARS-CoV-2 antibody detection; Statins help pancreatic tumors go from bad to worse.
Read More
Previous 1 2 … 117 118 119 120 121 122 123 124 125 … 175 176 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 25, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 25, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 24, 2025
  • BIO2025: John Crowley and Martin Makary

    BIO 2025: Makary lays out FDA’s path, launches pilot review program

    BioWorld
    On the same day that FDA Commissioner Martin Makary spoke in a fireside chat during the 2025 Biotechnology Innovation Organization’s International Convention, the...
  • Andembry

    New orphan drug, CSL’s garadacimab, cleared for hereditary angioedema

    BioWorld
    Following a complete response letter issued last October over CMC issues, CSL Behring LLC gained U.S. FDA approval June 16 of its humanized anti-factor XIIa...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe